Clinical Trial Update: Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and immune response of an HIV vaccine administered in the groin versus the arm; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, HIV Seronegativity | Phase 1 | Status: COMPLETED